Portfolio Holdings Detail for ISIN IE00BMX0DF60
Stock Name / Fund iShares US Medical Devices UCITS ETF
Issuer Blackrock
Entity holding fund iShares V Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF Ticker UMDV.AS(USD) CXE
ETF Ticker UMDV(USD) Euronext Amsterdam

Holdings detail for ATRC

Stock Name	AtriCure Inc
Ticker	ATRC(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US04963C2098

Show aggregate ATRC holdings

News associated with ATRC

AtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of “Buy” from Brokerages: AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) has been given a consensus recommendation of “Buy” by the nine brokerages that are covering the stock, MarketBeat Ratings reports. Nine analysts have rated the stock with a buy rating. The average 1 year price target among analysts that have issued ratings on the stock in the last […] - 2025-08-22 02:26:44
AtriCure, Inc. (NASDAQ:ATRC) Short Interest Up 46.1% in July: AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) saw a significant increase in short interest during the month of July. As of July 31st, there was short interest totaling 2,220,000 shares, anincreaseof46.1% from the July 15th total of 1,520,000 shares. Based on an average daily volume of 546,100 shares, the short-interest ratio is presently 4.1 days. […] - 2025-08-21 05:28:44
XTX Topco Ltd Makes New $526,000 Investment in AtriCure, Inc. (NASDAQ:ATRC): XTX Topco Ltd purchased a new position in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) during the first quarter, Holdings Channel reports. The firm purchased 16,301 shares of the medical device company’s stock, valued at approximately $526,000. A number of other hedge funds also recently bought and sold shares of the business. Hood River […] - 2025-08-07 05:01:01
Mackenzie Financial Corp Increases Position in AtriCure, Inc. (NASDAQ:ATRC): Mackenzie Financial Corp lifted its holdings in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 91.6% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 29,143 shares of the medical device company’s stock after acquiring an additional 13,929 shares during the quarter. Mackenzie Financial […] - 2025-08-06 05:07:47
AtriCure (NASDAQ:ATRC) Shares Gap Up on Strong Earnings: AtriCure, Inc. (NASDAQ:ATRC – Get Free Report)’s stock price gapped up prior to trading on Wednesday after the company announced better than expected quarterly earnings. The stock had previously closed at $31.73, but opened at $37.70. AtriCure shares last traded at $37.03, with a volume of 594,302 shares traded. The medical device company reported ($0.02) […] - 2025-08-01 02:07:09
Allianz Asset Management GmbH Has $3.96 Million Holdings in AtriCure, Inc. (NASDAQ:ATRC): Allianz Asset Management GmbH lifted its holdings in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 22.8% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 122,858 shares of the medical device company’s stock after acquiring an additional 22,838 shares during the period. Allianz Asset Management GmbH owned […] - 2025-07-29 04:44:56
AtriCure, Inc. (NASDAQ:ATRC) Receives Average Recommendation of “Buy” from Analysts: AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) has been given a consensus recommendation of “Buy” by the nine ratings firms that are covering the stock, Marketbeat Ratings reports. Nine research analysts have rated the stock with a buy recommendation. The average 12 month price target among brokerages that have updated their coverage on the stock […] - 2025-07-28 03:06:51
Mackenzie Financial Corp Takes Position in AtriCure, Inc. (NASDAQ:ATRC): Mackenzie Financial Corp acquired a new position in AtriCure, Inc. (NASDAQ:ATRC – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 15,214 shares of the medical device company’s stock, valued at approximately $465,000. Other institutional investors and hedge funds have also […] - 2025-06-04 05:16:59
AtriCure (NASDAQ:ATRC) Stock Rating Lowered by Wall Street Zen: Wall Street Zen cut shares of AtriCure (NASDAQ:ATRC – Free Report) from a buy rating to a hold rating in a research report released on Sunday morning. A number of other analysts also recently weighed in on ATRC. Piper Sandler upped their target price on shares of AtriCure from $40.00 to $50.00 and gave the […] - 2025-06-02 04:26:45
AtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Squarepoint Ops LLC: Squarepoint Ops LLC cut its holdings in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 64.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,472 shares of the medical device company’s stock after selling 101,207 shares during the […] - 2025-05-30 05:35:00
State of Wyoming Acquires 446 Shares of AtriCure, Inc. (NASDAQ:ATRC): State of Wyoming boosted its position in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 21.9% in the 4th quarter, HoldingsChannel reports. The firm owned 2,481 shares of the medical device company’s stock after buying an additional 446 shares during the period. State of Wyoming’s holdings in AtriCure were worth $76,000 at the end […] - 2025-05-29 05:08:55
ProShare Advisors LLC Increases Stock Holdings in AtriCure, Inc. (NASDAQ:ATRC): ProShare Advisors LLC grew its stake in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 49.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,330 shares of the medical device company’s stock after purchasing an additional 4,385 shares during the quarter. ProShare […] - 2025-05-28 05:13:03
Man Group plc Invests $745,000 in AtriCure, Inc. (NASDAQ:ATRC): Man Group plc purchased a new position in AtriCure, Inc. (NASDAQ:ATRC – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 24,368 shares of the medical device company’s stock, valued at approximately $745,000. Other institutional investors and hedge funds […] - 2025-05-26 05:01:05
AtriCure (NASDAQ:ATRC) Stock Rating Upgraded by Wall Street Zen: AtriCure (NASDAQ:ATRC – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday. A number of other analysts have also commented on ATRC. Stifel Nicolaus boosted their price objective on shares of AtriCure from $36.00 to $48.00 and gave […] - 2025-05-26 02:12:50
ATRC Crosses Below Key Moving Average Level: In trading on Friday, shares of AtriCure Inc (Symbol: ATRC) crossed below their 200 day moving average of $32.37, changing hands as low as $31.95 per share. AtriCure Inc shares are currently trading down about 0.8% on the day. The chart below shows the one year performance of - 2025-05-23 12:36:54
Nuveen Asset Management LLC Sells 149,584 Shares of AtriCure, Inc. (NASDAQ:ATRC): Nuveen Asset Management LLC decreased its position in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 12.6% during the fourth quarter, HoldingsChannel.com reports. The firm owned 1,037,348 shares of the medical device company’s stock after selling 149,584 shares during the quarter. Nuveen Asset Management LLC’s holdings in AtriCure were worth $31,701,000 as of its most recent […] - 2025-05-22 05:58:59
BNP Paribas Financial Markets Has $2.97 Million Holdings in AtriCure, Inc. (NASDAQ:ATRC): BNP Paribas Financial Markets lifted its position in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 676.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 97,310 shares of the medical device company’s stock after buying an additional 84,776 […] - 2025-05-16 06:02:57
Northern Trust Corp Increases Holdings in AtriCure, Inc. (NASDAQ:ATRC): Northern Trust Corp grew its holdings in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 11.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 483,607 shares of the medical device company’s stock after purchasing an additional 50,153 shares during the […] - 2025-05-16 04:38:56
Dimensional Fund Advisors LP Raises Position in AtriCure, Inc. (NASDAQ:ATRC): Dimensional Fund Advisors LP increased its stake in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 24.1% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 700,212 shares of the medical device company’s stock after acquiring an additional 136,015 shares during the quarter. Dimensional Fund Advisors LP’s holdings in AtriCure were worth $21,398,000 […] - 2025-05-08 04:45:00
Barclays PLC Has $2.64 Million Holdings in AtriCure, Inc. (NASDAQ:ATRC): Barclays PLC trimmed its holdings in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 33.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 86,541 shares of the medical device company’s stock after selling 42,724 shares during the quarter. Barclays PLC’s holdings in AtriCure were worth […] - 2025-05-01 05:14:58
AtriCure (NASDAQ:ATRC) Trading Up 4.9% After Better-Than-Expected Earnings: AtriCure, Inc. (NASDAQ:ATRC – Get Free Report)’s share price traded up 4.9% on Tuesday following a stronger than expected earnings report. The company traded as high as $35.19 and last traded at $35.31. 373,568 shares were traded during mid-day trading, a decline of 43% from the average session volume of 654,896 shares. The stock had […] - 2025-05-01 02:40:58
Envestnet Asset Management Inc. Cuts Position in AtriCure, Inc. (NASDAQ:ATRC): Envestnet Asset Management Inc. decreased its stake in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 4.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 46,086 shares of the medical device company’s stock after selling 2,104 shares during the period. Envestnet Asset Management […] - 2025-04-30 04:42:56
Raymond James Financial Inc. Acquires Shares of 121,591 AtriCure, Inc. (NASDAQ:ATRC): Raymond James Financial Inc. acquired a new stake in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 121,591 shares of the medical device company’s stock, valued at approximately $3,716,000. Several other hedge […] - 2025-04-27 06:26:45
AtriCure (NASDAQ:ATRC) and KORU Medical Systems (NASDAQ:KRMD) Financial Survey: AtriCure (NASDAQ:ATRC – Get Free Report) and KORU Medical Systems (NASDAQ:KRMD – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends. Valuation and Earnings This table compares AtriCure […] - 2025-04-22 02:50:55
Townsquare Capital LLC Decreases Stake in AtriCure, Inc. (NASDAQ:ATRC): Townsquare Capital LLC decreased its holdings in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 4.7% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 16,138 shares of the medical device company’s stock after selling 789 shares during the period. Townsquare Capital LLC’s holdings in AtriCure were worth $493,000 […] - 2025-04-21 05:26:42
JPMorgan Chase & Co. Buys 110,039 Shares of AtriCure, Inc. (NASDAQ:ATRC): JPMorgan Chase & Co. increased its stake in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 43.1% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 365,183 shares of the medical device company’s stock after acquiring an additional 110,039 shares during the quarter. JPMorgan Chase & Co.’s holdings in AtriCure were worth $11,160,000 […] - 2025-04-14 04:39:04
Corebridge Financial Inc. Reduces Holdings in AtriCure, Inc. (NASDAQ:ATRC): Corebridge Financial Inc. lowered its stake in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 7.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 23,535 shares of the medical device company’s stock after selling 1,776 shares during the quarter. Corebridge Financial Inc.’s […] - 2025-04-07 04:32:51
Analysts Set AtriCure, Inc. (NASDAQ:ATRC) Target Price at $51.56: Shares of AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) have earned an average recommendation of “Buy” from the nine analysts that are currently covering the firm, MarketBeat.com reports. Nine investment analysts have rated the stock with a buy rating. The average 1-year price objective among brokers that have issued ratings on the stock in the […] - 2025-03-28 04:56:46
Needham & Company LLC Reaffirms “Buy” Rating for AtriCure (NASDAQ:ATRC): Needham & Company LLC reaffirmed their buy rating on shares of AtriCure (NASDAQ:ATRC – Free Report) in a research report sent to investors on Friday,Benzinga reports. They currently have a $51.00 price target on the medical device company’s stock. Several other analysts also recently commented on ATRC. JMP Securities reaffirmed a “market outperform” rating and […] - 2025-03-24 04:34:46
Analysts See 32% Gains Ahead For The Holdings of ESML: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-03-12 09:42:28

iShares US Medical Devices UCITS ETF ATRC holdings

Date	Number of ATRC Shares Held	Base Market Value of ATRC Shares	Local Market Value of ATRC Shares	Change in ATRC Base Value	Current Price per ATRC Share Held	Previous Price per ATRC Share Held
2025-12-03 (Wednesday)	6,897	USD 250,430	USD 250,430	USD 6,897	USD 36.31	USD 35.31
2025-12-02 (Tuesday)	6,897	USD 243,533	USD 243,533	USD 1,517	USD 35.31	USD 35.09
2025-12-01 (Monday)	6,897	USD 242,016	USD 242,016	USD -7,104	USD 35.09	USD 36.1201
2025-11-28 (Friday)	6,897	USD 249,120	USD 249,120	USD 621	USD 36.1201	USD 36.03
2025-11-27 (Thursday)	6,897	USD 248,499	USD 248,499	USD 0	USD 36.03	USD 36.03
2025-11-26 (Wednesday)	6,897	USD 248,499	USD 248,499	USD -16,898	USD 36.03	USD 38.4801
2025-11-25 (Tuesday)	6,897	USD 265,397	USD 265,397	USD 5,104	USD 38.4801	USD 37.74
2025-11-24 (Monday)	6,897	USD 260,293	USD 260,293	USD 10,829	USD 37.74	USD 36.1699
2025-11-21 (Friday)	6,897	USD 249,464	USD 249,464	USD 20,139	USD 36.1699	USD 33.25
2025-11-20 (Thursday)	6,897	USD 229,325	USD 229,325	USD -6,414	USD 33.25	USD 34.1799
2025-11-19 (Wednesday)	6,897	USD 235,739	USD 235,739	USD 7,034	USD 34.1799	USD 33.1601
2025-11-18 (Tuesday)	6,897	USD 228,705	USD 228,705	USD 276	USD 33.1601	USD 33.1201
2025-11-17 (Monday)	6,897	USD 228,429	USD 228,429	USD 1,518	USD 33.1201	USD 32.9

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ATRC by Blackrock for IE00BMX0DF60

Show aggregate share trades of ATRC

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-06 SELL -112 32.160 31.430 31.503 USD -3,528 34.51 Profit of 337 on sale
2025-11-04 BUY 56 34.555 32.720 32.904 USD 1,843 34.53
2025-10-30 SELL -168 36.860 30.935 31.527 USD -5,297 34.53 Profit of 505 on sale
2025-10-23 SELL -56 37.390 37.750 37.714 USD -2,112 34.48 Loss of -181 on sale
2025-10-22 BUY 112 37.110 37.730 37.668 USD 4,219 34.46
2025-10-20 BUY 55 37.460 38.110 38.045 USD 2,092 34.43
2025-10-16 BUY 56 37.240 37.830 37.771 USD 2,115 34.40
2025-09-25 BUY 432 35.030 35.820 35.741 USD 15,440 34.36
2025-06-27 SELL -110 32.280 32.940 32.874 USD -3,616 34.63 Profit of 193 on sale
2025-06-12 BUY 162 32.330 33.260 33.167 USD 5,373 34.79
2025-06-10 SELL -864 33.390 34.380 34.281 USD -29,619 34.81 Profit of 461 on sale
2025-06-09 SELL -1,026 34.180 35.240 35.134 USD -36,047 34.82 Loss of -322 on sale
2025-05-30 SELL -108 34.570 34.760 34.741 USD -3,752 34.83 Profit of 9 on sale
2025-05-19 BUY 54 32.400 32.680 32.652 USD 1,763 34.95
2025-05-09 SELL -285 30.990 31.590 31.530 USD -8,986 35.12 Profit of 1,022 on sale
2025-04-23 SELL -57 32.490 34.230 34.056 USD -1,941 35.57 Profit of 86 on sale
2025-04-17 SELL -56 32.010 33.500 33.351 USD -1,868 35.73 Profit of 133 on sale
2025-04-10 BUY 448 31.640 33.280 33.116 USD 14,836 35.94
2025-04-04 SELL -112 31.310 32.150 32.066 USD -3,591 36.14 Profit of 457 on sale
2025-04-02 SELL -112 34.130 34.300 34.283 USD -3,840 36.17 Profit of 211 on sale
2025-03-31 SELL -168 32.260 32.550 32.521 USD -5,464 36.25 Profit of 627 on sale
2025-03-19 SELL -54 34.820 35.170 35.135 USD -1,897 36.49 Profit of 73 on sale
2025-02-28 SELL -108 38.740 38.930 38.911 USD -4,202 36.75 Loss of -233 on sale
2025-02-05 BUY 168 41.330 41.350 41.348 USD 6,946 35.41
2025-02-04 BUY 224 40.650 40.920 40.893 USD 9,160 35.28
2025-01-29 SELL -55 42.400 43.110 43.039 USD -2,367 34.72 Loss of -458 on sale
2025-01-23 SELL -56 40.370 40.480 40.469 USD -2,266 33.99 Loss of -363 on sale
2025-01-02 SELL -108 30.400 30.970 30.913 USD -3,339 34.09 Profit of 344 on sale
2024-12-04 BUY 162 36.310 36.930 36.868 USD 5,973 34.02
2024-12-03 SELL -54 36.120 37.040 36.948 USD -1,995 33.94 Loss of -162 on sale
2024-12-02 SELL -648 37.060 37.330 37.303 USD -24,172 33.82 Loss of -2,257 on sale
2024-11-29 SELL -1,080 36.160 37.250 37.141 USD -40,112 33.73 Loss of -3,688 on sale
2024-11-27 SELL -162 36.170 36.470 36.440 USD -5,903 33.51 Loss of -474 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-06	SELL	-112	32.160	31.430	31.503	USD -3,528	34.51 Profit of 337 on sale
2025-11-04	BUY	56	34.555	32.720	32.904	USD 1,843	34.53
2025-10-30	SELL	-168	36.860	30.935	31.527	USD -5,297	34.53 Profit of 505 on sale
2025-10-23	SELL	-56	37.390	37.750	37.714	USD -2,112	34.48 Loss of -181 on sale
2025-10-22	BUY	112	37.110	37.730	37.668	USD 4,219	34.46
2025-10-20	BUY	55	37.460	38.110	38.045	USD 2,092	34.43
2025-10-16	BUY	56	37.240	37.830	37.771	USD 2,115	34.40
2025-09-25	BUY	432	35.030	35.820	35.741	USD 15,440	34.36
2025-06-27	SELL	-110	32.280	32.940	32.874	USD -3,616	34.63 Profit of 193 on sale
2025-06-12	BUY	162	32.330	33.260	33.167	USD 5,373	34.79
2025-06-10	SELL	-864	33.390	34.380	34.281	USD -29,619	34.81 Profit of 461 on sale
2025-06-09	SELL	-1,026	34.180	35.240	35.134	USD -36,047	34.82 Loss of -322 on sale
2025-05-30	SELL	-108	34.570	34.760	34.741	USD -3,752	34.83 Profit of 9 on sale
2025-05-19	BUY	54	32.400	32.680	32.652	USD 1,763	34.95
2025-05-09	SELL	-285	30.990	31.590	31.530	USD -8,986	35.12 Profit of 1,022 on sale
2025-04-23	SELL	-57	32.490	34.230	34.056	USD -1,941	35.57 Profit of 86 on sale
2025-04-17	SELL	-56	32.010	33.500	33.351	USD -1,868	35.73 Profit of 133 on sale
2025-04-10	BUY	448	31.640	33.280	33.116	USD 14,836	35.94
2025-04-04	SELL	-112	31.310	32.150	32.066	USD -3,591	36.14 Profit of 457 on sale
2025-04-02	SELL	-112	34.130	34.300	34.283	USD -3,840	36.17 Profit of 211 on sale
2025-03-31	SELL	-168	32.260	32.550	32.521	USD -5,464	36.25 Profit of 627 on sale
2025-03-19	SELL	-54	34.820	35.170	35.135	USD -1,897	36.49 Profit of 73 on sale
2025-02-28	SELL	-108	38.740	38.930	38.911	USD -4,202	36.75 Loss of -233 on sale
2025-02-05	BUY	168	41.330	41.350	41.348	USD 6,946	35.41
2025-02-04	BUY	224	40.650	40.920	40.893	USD 9,160	35.28
2025-01-29	SELL	-55	42.400	43.110	43.039	USD -2,367	34.72 Loss of -458 on sale
2025-01-23	SELL	-56	40.370	40.480	40.469	USD -2,266	33.99 Loss of -363 on sale
2025-01-02	SELL	-108	30.400	30.970	30.913	USD -3,339	34.09 Profit of 344 on sale
2024-12-04	BUY	162	36.310	36.930	36.868	USD 5,973	34.02
2024-12-03	SELL	-54	36.120	37.040	36.948	USD -1,995	33.94 Loss of -162 on sale
2024-12-02	SELL	-648	37.060	37.330	37.303	USD -24,172	33.82 Loss of -2,257 on sale
2024-11-29	SELL	-1,080	36.160	37.250	37.141	USD -40,112	33.73 Loss of -3,688 on sale
2024-11-27	SELL	-162	36.170	36.470	36.440	USD -5,903	33.51 Loss of -474 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ATRC

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	75,764	0	170,365	44.5%
2025-09-18	68,150	17	148,539	45.9%
2025-09-17	48,791	0	104,898	46.5%
2025-09-16	147,271	0	190,380	77.4%
2025-09-15	233,478	0	319,066	73.2%
2025-09-12	193,594	0	286,138	67.7%
2025-09-11	256,897	0	327,489	78.4%
2025-09-10	112,455	30	233,609	48.1%
2025-09-09	111,431	0	139,764	79.7%
2025-09-08	71,626	0	145,780	49.1%
2025-09-05	45,694	0	89,387	51.1%
2025-09-04	52,064	0	96,301	54.1%
2025-09-03	135,433	0	192,545	70.3%
2025-09-02	107,759	1,850	176,495	61.1%
2025-08-29	55,705	0	95,376	58.4%
2025-08-28	58,317	0	91,024	64.1%
2025-08-27	25,898	0	58,260	44.5%
2025-08-26	75,103	0	101,685	73.9%
2025-08-25	99,545	0	129,039	77.1%
2025-08-22	156,328	0	201,036	77.8%
2025-08-21	60,501	0	82,918	73.0%
2025-08-20	82,638	0	129,298	63.9%
2025-08-19	146,235	0	190,741	76.7%
2025-08-18	107,695	0	175,576	61.3%
2025-08-15	73,277	0	113,494	64.6%
2025-08-14	101,489	0	146,417	69.3%
2025-08-13	92,778	0	135,205	68.6%
2025-08-12	63,361	2	182,030	34.8%
2025-08-11	101,105	1,225	267,497	37.8%
2025-08-08	66,584	0	127,311	52.3%
2025-08-07	109,839	0	173,947	63.1%
2025-08-06	155,847	0	248,439	62.7%
2025-08-05	174,601	0	279,099	62.6%
2025-08-04	310,759	0	385,352	80.6%
2025-08-01	162,340	600	255,821	63.5%
2025-07-31	172,073	0	285,817	60.2%
2025-07-30	845,185	2,557	1,422,495	59.4%
2025-07-29	132,608	0	284,229	46.7%
2025-07-28	272,580	0	451,799	60.3%
2025-07-25	106,898	3	202,926	52.7%
2025-07-24	66,169	0	155,270	42.6%
2025-07-23	113,125	0	207,978	54.4%
2025-07-22	95,307	0	153,047	62.3%
2025-07-21	76,931	0	130,826	58.8%
2025-07-18	64,716	0	97,343	66.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares US Medical Devices UCITS ETF
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	UMDV.AS(USD) CXE
ETF Ticker	UMDV(USD) Euronext Amsterdam